Routine, Urgent or Emergency: Triaging the Post-Filler Phone Call

Post-filler phone call triage is a decision you make before you have a diagnosis, and that is the entire difficulty of it. A patient calls at 6:40 in the evening. Something is different. You have no tissue in front of you, no capillary refill, no temperature, no before photograph on the screen, and no way to know yet whether you are hearing a bruise or an evolving ischemic event. You still have to decide something in the next ninety seconds.

Michelle Langston teaches injectors to sort that call into one of three tiers — routine, urgent, or emergency — and to do it on trajectory and findings rather than on a diagnosis nobody has yet. "The first decision is this: routine, urgent or emergency," she says. The tier is not a guess at the pathology. It is a decision about how fast the patient needs to be in front of a clinician, and whether that clinician is you or an emergency physician.

That distinction matters because diagnosis is slow and perfusion is not. If you wait for certainty before acting, you have spent the window in which the enzyme is most useful. Triage is what lets you act on suspicion.

Why the tier comes before the diagnosis

An occlusion is a perfusion problem. Tissue distal to the blockage is not receiving oxygen, and the clock on that tissue started when the filler entered the vessel, not when the patient noticed. Every triage system used in emergency medicine exists for the same reason: sorting has to be faster than diagnosing, because sorting determines who gets seen first, and seeing is what produces the diagnosis.

Applied to a post-filler call, the logic runs like this. You are not asking "is this a vascular occlusion?" You are asking "what is the cost of being wrong in each direction?" Over-triage — bringing in a patient with an ordinary bruise — costs you a room and thirty minutes. Under-triage — reassuring by phone a patient whose upper lip is mottling — costs tissue. Those costs are not symmetrical, and the framework is built around that asymmetry. When the tier is uncertain, you move up, not down.

Langston is blunt about the failure mode: "I don't know if it's because we don't want to believe something is wrong. We're excited about the result. And maybe the result looks amazing, but then the patient starts to complain about pain out of proportion to where we injected, and so we're thinking, that can't be, it looks great. So it can't be an occlusion. It could be an occlusion."

A beautiful result is not evidence against ischemia. It is the reason the ischemia gets missed.

Tier 1 — Routine

Routine is the expected injection response. Erythema at the puncture sites, oedema proportionate to the volume placed, a bruise that behaves like a bruise, and discomfort that fits the procedure the patient had. The pattern is symmetric where the treatment was symmetric. The colour returns on pressure at the same rate as the surrounding skin. Most importantly, the trajectory is flat or improving.

What routine gets: documentation, a scheduled follow-up contact, and an explicit red-flag brief. That last item is the part most practices skip. The patient needs to know — in specific, non-frightening language — what would make them call back and how fast: any change in vision, pain that is getting worse rather than better, skin that goes pale, white, dusky or blotchy, or an area that feels cool to the touch.

Routine also gets a follow-up call the next day. Langston builds that call into the protocol deliberately, because the urgent tier frequently does not announce itself in the chair. "This may not be the day the patient's in the chair. This is why we do our follow-up calls."

For the ordinary, non-vascular reactions that fill most of this tier — swelling, bruising, lumps, tenderness after lip work — our patient-facing overview of common lip filler reactions is a reasonable thing to send the patient after the call, once you have tiered them.

Tier 2 — Urgent

Urgent is the tier that does the work. Emergency is easy to recognise and routine is easy to dismiss; almost every case that ends badly was sitting in tier 2 and got filed as tier 1.

The urgent findings Langston names are changes from the patient's own baseline rather than absolute values: blanching in an area, swelling that is suddenly worse on one side, new asymmetry, discoloration beyond the treated point, pain that is escalating rather than settling, and the sentence she treats as a finding in its own right — "something isn't right." A patient who has had cheek filler three times before and tells you this one feels different is giving you data. "Move your ego out of these situations and really listen to the patient."

Two things make tier 2 harder than it looks.

The first is that pain is an unreliable sorter. Local anaesthetic masks it. After a lip block, a patient may have a developing occlusion and report very little discomfort, which is precisely why colour, capillary refill and temperature carry more weight than the pain score in the territories where blocks are routine.

The second is the photograph. A patient who texts you an image is trying to help, and the image will tell you almost nothing you need. It cannot give you capillary refill. It cannot give you skin temperature. It cannot give you trajectory, because it is a single frame. White balance on a phone camera will invent pallor or conceal it. Langston describes the situation she finds most frightening as exactly this one — "when you have a patient send you a photo like this, and we can't get them to come in."

The action for tier 2 is a same-day, in-person assessment. Not a phone reassurance. Not "send me another picture in an hour." Not an appointment tomorrow. The patient comes in, and you assess with the before photographs open on the screen.

Tier 3 — Emergency

Emergency has one automatic trigger and several findings-based ones.

Any visual symptom is an automatic emergency. Blurred vision, a visual field change, double vision, eye pain, ptosis — any of it. There is no watch-and-wait tier for vision. "If there's a visual change, there is no watch and wait. Immediately you invoke your emergency protocol. You're calling 911." For the mechanism behind ocular events after facial injection, our piece on whether injectables can cause blindness covers the anatomy of retrograde flow into the ophthalmic circulation.

The other emergency findings are perfusion findings: pallor or frank blanching, delayed capillary refill, dusky or violaceous discoloration, reticular or lacy mottling, and skin that is cool relative to the adjacent face.

The action is simultaneous, not sequential. Call 911. Begin flooding the territory with hyaluronidase while you wait. Do not send the patient to the emergency department on their own, and do not let a patient leave the office in any tier until perfusion is stable. Treatment continues through the waiting period — the ambulance is transport, not therapy, and the enzyme is in your hand and not in theirs.

The triage table

Who takes the call, and what they ask

In most practices the person who first hears "something is different" is not the injector. It is whoever answers the phone. That person does not need to triage — they need to collect the five answers that let you triage, and to know the one that ends the conversation.

1. What has changed, and where exactly?
2. When did it start, and is it worse than it was an hour ago?
3. Is there any change in your vision?
4. Press on the area for a few seconds and let go — does the colour come back, and how quickly compared with the other side?
5. Does that area feel cool compared with the rest of your face?

Question 3 is the stop. If the answer is yes, the front desk does not take a message, does not offer an appointment and does not go looking for you — the standing instruction is to put the call through immediately and to activate the emergency protocol.

The other four give you tier 1 versus tier 2 in about a minute. Write them on a card at the phone. Langston's broader point about preparation applies here as much as anywhere: "the most important thing is to prepare for the emergency when you don't have the emergency."

What happens after the tier is set

Tiering is not a one-time decision. A patient triaged as urgent at 6:40 and seen at 7:15 can be an emergency at 7:30, and the reassessment cycle is what catches that. Once the patient is in front of you, the framework hands off to serial assessment: mark and outline the affected border, timestamp it, check capillary refill, temperature and pain, and repeat the cycle every 15 to 20 minutes so that you are reading direction rather than a snapshot.

Treatment, when a vascular component is suspected, is enzyme to the whole territory rather than a hunt for the vessel. In Langston's protocol the initial flooding dose sits in the range of 450 to 1,500 units, reassessed at 15 to 20 minutes and repeated until capillary refill and colour return. The endpoint is perfusion, not appearance. Adjunctive measures exist and she names them in passing; they are secondary to the enzyme and are outside the scope of this article.

These figures reflect Michelle Langston's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.

A triage framework is only as good as the assessment skill underneath it, and that skill is anatomical before it is procedural. Empire's Complete Dermal Filler Training and Anatomical Based Aesthetics Training cover the vascular territories and injection planes that determine what a given presentation is likely to mean. For the patient-facing side of dissolution, our overview of filler dissolving is the page to send them to — it answers what they are about to ask without you having to.

Related guides in this cluster

Part of Vascular Occlusion: Recognition and Response.

Clinical GuideThe Expected Filler Injection Response — Building the Baseline That Lets You Recognize IschemiaThe expected filler injection response — erythema, edema, ecchymosis — and how a trained normal baseline makes early ischemia recogniza Clinical GuideThe Golden Triangle — Why the Filler Deposit Site Isn't Where You Put the Needle InThe filler deposit site sits at the needle tip, not the entry point — about half an inch away, further with a cannula. Why that gap dec Clinical GuideImmediate, Early and Late — The Three Windows of Vascular Occlusion OnsetVascular occlusion onset is not one moment. Organize the picture into immediate, early and late windows — detection runs days past the